Scarica l'app Stockscreener
4.59
1.08%
-0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.64
Aprire:
$4.69
Volume 24 ore:
1.37M
Relative Volume:
1.13
Capitalizzazione di mercato:
$669.84M
Reddito:
$389.42M
Utile/perdita netta:
$30.70M
Rapporto P/E:
22.47
EPS:
0.2043
Flusso di cassa netto:
$67.23M
1 W Prestazione:
-1.71%
1M Prestazione:
+0.88%
6M Prestazione:
+17.09%
1 anno Prestazione:
-31.59%
Intervallo 1D:
$4.485
$4.69
Intervallo di 1 settimana:
$4.485
$4.725
Portata 52W:
$3.025
$7.97
Mimedx Group Inc Stock (MDXG) Company Profile
Nome
Mimedx Group Inc
Settore
Industria
Telefono
(770) 651-9100
Indirizzo
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG vs MOBBW, PSNYW, GOODO, SHMD, CHAD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.34 | 1.62B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
4.19 | 689.98M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
18.63 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
4.57 | 291.21M | 52.15M | -21.46M | 0 | -0.4675 |
CHAD
Direxion Daily CSI 300 China A
|
9.10 | 197.39M | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-23 | Iniziato | Citizens | Mkt Outperform |
| 2024-07-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-03-07 | Iniziato | Lake Street | Buy |
| 2023-10-27 | Iniziato | Craig Hallum | Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2021-07-26 | Iniziato | Northland Capital | Outperform |
| 2021-03-19 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Mimedx Group Inc Borsa (MDXG) Ultime notizie
What's Driving the Buzz Around MiMedx Group, Inc. (MDXG) in Healthcare Stocks? - Kalkine Media
What Does the AXIOFILL Court Ruling Mean for MiMedx (NASDAQ:MDXG)? - Kalkine Media
MiMedx Group: Court Remands Both Matters to FDA for Further Consideration Consistent With Order >MDXG - Moomoo
MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter - Investing News Network
Court vacates FDA rulings on MiMedx’s AXIOFILL classification - Investing.com
U.S. District Court Orders FDA to Reclassify MiMedx Wound Powder as Device - Lawxy AI
FDA Must Revisit MiMedx Wound Care Powder Classification - Law360
MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 53.85% Potential Upside in Biotechnology - DirectorsTalk Interviews
MiMedx Group stock steadies as investors look to upcoming catalysts - AD HOC NEWS
MiMedx Group (MDXG) Holds Steady at $4.76 as Traders Eye $5.00 ResistanceMerger Arbitrage - careplusvn.com
Cantor Fitzgerald reiterates Overweight on MiMedx stock at $8 By Investing.com - Investing.com India
Two New York conferences will include MIMEDX executives on Sept. 9 and 10 - Stock Titan
MIMEDX GROUP, INC. SEC Filing (Sep 8, 2026) - Stock Titan
Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx - The Globe and Mail
MDXG Should I Buy - Intellectia AI
MiMedx (MDXG) Earnings Snapshot: Profit Per Share Falls Below Its Benchmark in the Reported Period; Session Move - dars.gov.et
MiMedx Group (NASDAQ: MDXG) readies shares for business combination - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc.MDXG - Eastern Progress
Sanara MedTech (SMTI) agrees to MiMedx takeover, targeting year-end close - Stock Titan
MiMedx (MDXG) Earnings Metrics: The Bottom-Line Figure Trails Its Comparison at the Close; Immediate Response: Shares Move 3.58% Up on the DayEnergy Earnings Report - vinanet.vn
MDXG Q2 2026 Earnings: Wider-than-Expected Loss as EPS Misses Estimates by 106%Post-Announcement Reaction - vinanet.vn
Tranche Update on MiMedx Group, Inc.'s Equity Buyback Plan announced on February 25, 2026. - marketscreener.com
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Sanara MedTech Corrects Termination Fees in Merger Deal with MiMedx - Kalkine Media
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan
MiMedx Group, Inc (MDXG) Stock Report: Exploring a 63.93% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
MiMedx Group Inc (MDXG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MiMedx Group, Inc Revenue Breakdown – NASDAQ:MDXG - TradingView
MiMedx Group (MDXG) Climbs 3.83% to $4.34, Approaching Key Resistance LevelPrice Action Signals - dars.gov.et
MiMedx (MDXG) Q2 2026 Earnings Call Transcript - AOL.com
MiMedx Group Inc (MDXG) Stock News Today - TradingKey
MiMedx Group's (NASDAQ:MDXG) Soft Earnings Are Actually Better Than They Appear - simplywall.st
Lazard Asset Management LLC Sells 264,718 Shares of MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group (MDXG) Holds Steady Near $4.24 as Consolidation ContinuesUnusual Put Volume - dars.gov.et
MiMedx Group (NASDAQ:MDXG) Stock Price Up 7.8%What's Next? - MarketBeat
Renaissance Technologies LLC Has $11.93 Million Stake in MiMedx Group, Inc $MDXG - MarketBeat
Wall Street Zen Downgrades MiMedx Group (NASDAQ:MDXG) to Sell - MarketBeat
Mimedx to buy Sanara for $350M to move beyond wound care - bioworld.com
MiMedx to Buy Sanara MedTech for $350M - Medical Product Outsourcing
MiMedx to acquire Sanara MedTech for $350M - MassDevice
MiMedx Group affirms FY26 sales guidance of $260-290M - scanx.trade
MiMedx Group Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
MiMedx Group Q2 Earnings Call Highlights - tradingview.com
MiMedx Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is MiMedx Group Inc (MDXG) Undervalued After Q2 Earnings Beat? E - GuruFocus
MiMedx: Q2 Earnings Snapshot - Marietta Daily Journal
MIMEDX to Acquire Sanara MedTech - The Manila Times
MIMEDX Announces Second Quarter 2026 Operating & Financial Results - GlobeNewswire
MiMedx agrees to buy Sanara MedTech for $35 a share (SMTI:NASDAQ) - Seeking Alpha
Earnings To Watch: MiMedx Group Inc (MDXG) Q2 2026 -- GF Value Sees 35% Upside - GuruFocus
Mimedx Group Inc Azioni (MDXG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mimedx Group Inc Azioni (MDXG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hulse William Frank IV | General Counsel and CAO |
Mar 10 '26 |
Option Exercise |
4.50 |
136,364 |
613,638 |
624,900 |
| DOUG RICE | Chief Financial Officer |
Mar 10 '26 |
Option Exercise |
4.50 |
243,000 |
1,093,500 |
508,678 |
| Maersk-Moller Kimberly | Chief Commercial Officer |
Nov 06 '25 |
Sale |
7.42 |
58,300 |
432,329 |
236,982 |
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):